This fascinating article discusses Glatiramir Acetate, which is a drug that is used in the treatment of multiple sclerosis, a disease in which the individuals’ immune system attacks the myelin sheath of the nerves and slowly degrades the nervous system. However a new discovery has led scientists to discover that the drug is also quite successful at killing Gram-negative bacteria, specifically Pseudomonas aeruginosa, which causes pneumonia and has become alarming resistant to many antibiotics frequently used in treatment. This discovery gives doctors a new tool in fighting various diseases, like pneumonia and septic shock. Currently the treatment method consists of ineffective antibiotics and the use of other medicaments in such high doses that they can actually harm the patient. One of the most appealing things about this drug is the fact that it’s currently on the market and approved for use which saves company and scientist time, money and energy by avoiding the approval process, which in turn can save lives. It also allowed for further advancement in the treatment of MS, which has numerous benefits as well.
Recent comments